Shi, X. (2026) “Pathological Complete Response in Stage IV Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer With Synchronous Liver Metastases After Conversion Therapy With SOX Plus Cadonilimab and Disitamab Vedotin”, Gastroenterology Research, 19(5), pp. 295–301. doi:10.14740/gr2193.